BioMarin Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
26.02.26
/
50%
€51.78
Target price
26.02.27
€87.99
Performance (%)
-13.04%
Price
27.05.26
€45.03
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -13.04%. This prediction currently runs until 26.02.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 4.333% | 4.333% |
| iShares Core DAX® | 3,76 % | 3,97 % |
| iShares Nasdaq 100 | 3,86 % | 10,79 % |
| iShares Nikkei 225® | 7,44 % | 10,69 % |
| iShares S&P 500 | 2,04 % | 5,89 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) was given a new $104.00 price target by Canaccord Genuity Group Inc.. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.24
22.05.26
22.05.26
€95.52
22.05.27
22.05.27
-2.62%
27.05.26
27.05.26
